SpringWorks Therapeutics Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 0
Bid Price 20.00
Ask Price 27.80
News -
Day High


52 Week Range


Day Low
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
SpringWorks Therapeutics Inc SWTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 26.69 20:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 13.60 - 89.7458
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 26.69 USD


Draw Mode:

SpringWorks Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.32B 49.41M 28.40M $ - $ - -3.59 -6.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 120.82k 4.90%

more financials information »

SpringWorks Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SWTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week21.9627.7221.9625.161,379,8844.7321.54%
1 Month18.0927.8218.0922.251,607,6678.6047.54%
3 Months59.1761.6213.6028.261,289,593-32.48-54.89%
6 Months63.9266.11513.6036.52820,056-37.23-58.24%
1 Year84.9089.745813.6045.57552,875-58.21-68.56%
3 Years24.5096.4813.6049.69352,2932.198.94%
5 Years24.5096.4813.6049.69352,2932.198.94%

SpringWorks Therapeutics Description

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220628 07:09:48